Quest Diagnostics Incorporated Profile Avatar - Palmy Investing

Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical …
Medical - Diagnostics & Research
US, Secaucus [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 33% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -25.81 0.97 1.31
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 0.57 11.21 11.15
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.90 57.95 56.31
Cash -30.28 4.27 6.13
Capex -45.75 -0.94 -0.64
Free Cash Flow -88.91 0.45 4.06
Revenue 4.34 21.32 20.43
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -1.34 0.32 0.32
Operating Margin -0.81 0.13 0.14
ROA 1.53 0.01 0.01
ROE -0.92 0.03 0.03
ROIC -8.22 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of DGX is permitted for members.
5 Growth
The "Growth Entry" for the Focus of DGX is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of DGX is permitted for members.
End of DGX's Analysis
CIK: 1022079 CUSIP: 74834L100 ISIN: US74834L1008 LEI: - UEI: -
Secondary Listings